Ferric carboxymaltose
The medicine ferric carboxymaltose.
- Drug
- In 2 atlases
Overview
Technical summary
RxNorm concept 1433693 is the ingredient ferric carboxymaltose (term type IN). The federal Substance Registration System lists UNII 6897GXD6OE as the polymer substance FERRIC CARBOXYMALTOSE. MeSH has it as supplementary concept record C522335, not as a descriptor. This identity is the substance only. It covers no dose, product or use, and the uses of ferric carboxymaltose belong to the interventions and recommendations that cite it.
Trials at a glance
The figures count the 8 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.
- Trials
- 8
- Phase 3 or 4
- 8
- Recruiting
- 3
- Regulatory decisions
- 0
| Phase | Recruiting | Completed | Unknown status | All statuses |
|---|---|---|---|---|
| Phase 3 | 1 | 2 | 0 | 3 |
| Phase 4 | 2 | 1 | 2 | 5 |
| All phases | 3 | 3 | 2 | 8 |
Conditions these trials study
- Aortic stenosis
- Heart valve disease
- Aortic aneurysm
- Heart failure
- Acute coronary syndrome
- Coronary artery disease
- Heart attack (myocardial infarction)
- Thoracic aortic aneurysm
- Type 2 diabetes
Sponsors with the most trials
- American Regent, Inc.
- Erasmus Medical Center
- Fundación para la Investigación del Hospital Clínico de Valencia
- GWT-TUD GmbH
- Hospital de Santa Cruz, Portugal
About this drug
- Level
- Substance
- Mechanism
- Not reported
Claims and evidence
No claims are published for this drug yet.
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 8
Record details
- Record id
core:ferric-carboxymaltose- Content hash
8b5b94e3b4e732f55fab01badb2b49a1b1bd2d6f8e787962b7f33af0cb68a323